Zevra Therapeutics benefits

Zevra Therapeutics develops and commercializes therapeutics for rare diseases.

3 recorded benefits. Record edited: Thu Sep 17 2026 02:45:14 GMT-0700 (Mountain Standard Time). Record edits are not policy checks. Confirm current terms and eligibility.

Recorded work model: Varies by role; the current board lists Boston office roles and remote U.S. regional Medical Science Liaison roles.. Company-wide eligibility is not established by this label.

401k

Availability: listed

The current official Zevra 2026 Form 10-K says the company has a 401(k) retirement plan covering substantially all employees; plan design and eligibility details beyond that statement are not stated.

Policy checked: Not recorded. Countries: Unknown. Employee classes: Unknown. Roles: Unknown. Conditions: Not recorded.

  • Zevra Therapeutics, Inc. 2025 Form 10-K

    Current official annual filing for fiscal year ended December 31, 2025; current identity/status, headquarters, company size, rare-disease business, and employee retirement/profit-sharing plans.. Accessed: 2026-09-17T09:43:05.866Z; published: 2026-03-09T00:00:00.000Z.

401k Match

Availability: listed

The current official Zevra 2026 Form 10-K says the company may provide a discretionary match of up to 4% of participant compensation, vesting immediately; the match is discretionary and no other formula or eligibility term is stated.

Policy checked: Not recorded. Countries: Unknown. Employee classes: Unknown. Roles: Unknown. Conditions: Not recorded.

  • Zevra Therapeutics, Inc. 2025 Form 10-K

    Current official annual filing for fiscal year ended December 31, 2025; current identity/status, headquarters, company size, rare-disease business, and employee retirement/profit-sharing plans.. Accessed: 2026-09-17T09:43:05.866Z; published: 2026-03-09T00:00:00.000Z.

Profit Sharing

Availability: listed

The current official Zevra 2026 Form 10-K says a discretionary profit-sharing plan covers all employees and employees become eligible after three years of service; it records no contributions in 2025 or 2024, so no contribution amount is implied.

Policy checked: Not recorded. Countries: Unknown. Employee classes: Unknown. Roles: Unknown. Conditions: Not recorded.

  • Zevra Therapeutics, Inc. 2025 Form 10-K

    Current official annual filing for fiscal year ended December 31, 2025; current identity/status, headquarters, company size, rare-disease business, and employee retirement/profit-sharing plans.. Accessed: 2026-09-17T09:43:05.866Z; published: 2026-03-09T00:00:00.000Z.